Since its introduction in 1924 by Rosenthal and White (1) , the dye sulfobromophthalein sodium (BSP) has proven useful not only for clinical purposes but also for physiological investigations of splanchnic vascular perfusion, hepatocellular function, and biliary secretory mechanisms. It has been shown that removal of BSP from the plasma by the liver depends upon two distinct processes: 1) accumulation of dye in hepatic cells and 2) active secretion into the biliary tract.
Hepatocellular accumulation or "storage" of BSP was first suggested by the demonstration of a marked delay between removal from the blood and excretion into the bile after the dye was administered intravenously to dogs (2, 3) , and a similar mechanism in man was inferred from a study of the hepatic removal of successive doses of BSP (4) . The accumulation of a related phthalein dye, fluorescein, in hepatic polygonal cells has actually been visualized in living frog and rat livers by the technique of fluorescence microscopy (5, 6) . In the case of another phthalein dye, I131-labeled rose bengal, an accumulation or "storage phase" is apparent in the curves obtained by external counting over the liver after intravenous injection (7) , and high concentration within liver cells has been confirmed by radioautography (8) . Although it has been suggested that accumulation of BSP may proceed until there is complete "saturation" of intrahepatic storage sites (4, 9) , more recent evidence indicates that the process tends toward an equilibrium state in which the quantity (and hence the concentration) of BSP in the liver is directly proportional to the concentration of dye in the surrounding plasma (10) storage capacity" (S) as the number of milligrams of BSP stored in the liver per milligram per 100 ml of plasma concentration. The value of S can be estimated by comparison of the rates of movement of BSP into the liver associated with different rates of change of plasma concentration (10) . The method of calculation is described below.
The high concentrations of BSP observed in the bile (2) indicate that the ultimate excretion of this dye undoubtedly depends upon an active transport mechanism. There is convincing indirect evidence in the dog (9) (10) (11) , in the rabbit (12, 13) , and in man (14, 15) that the secretion of BSP into the bile is limited by a definite maximal rate, analogous to the transport maximum, or "Tm," which is demonstrable for many substances secreted by the renal tubules. For understandable technical reasons the BSP transport maximum has not, until the present, been measured directly by bile collection. Moreover, because of the nature of the BSP storage process, the rate of biliary secretion cannot be equated to the rate of hepatic removal of BSP from the plasma unless the plasma level is absolutely constant. An indirect estimation of the BSP transport maximum is possible, nevertheless, by analysis of the data obtained during determination of relative storage capacity (10) .
With a method at hand for the quantitation of BSP relative storage capacity and transport maximum, it has been possible to study hepatocellular function and biliary secretion in the unanesthetized dog and to evaluate the effect of hepatic disease on these processes in man. The results are presented in this paper. THEORETICAL 
CONSIDERATIONS
The hepatic removal rate of BSP at any instant must be equal to the sum of the biliary excretion rate plus the rate of accumulation (or minus the rate of deple-tion) of BSP in hepatic parenchymal storage. The biliary excretion rate, under conditions where the secretory transport mechanism is saturated, is equal by definition to Tm. If the number of milligrams of BSP stored in the liver cells per milligram per 100 ml of plasma BSP concentration is defined by the relative storage capacity, S, then the rate of accumulation (or depletion) of stored BSP will be equal to the product of S times the rate of change of plasma concentration (Ap/At). Thus hepatic removal rate, R, is a function of both the secretory and storage processes: (16) . The Tm is then equal to the value of R for which Ap/At = 0, and S is equal to the slope of the least squares line.
It should be noted that the relative storage capacity, S, as defined, has the dimensions of a volume (in hundreds of milliliters). In view of the relationship between BSP storage and plasma concentration (10) the hepatic storage compartment can be considered, in a sense, as an extension of the plasma volume. When regarded in this way the present method is quite similar to one of the techniques proposed by Lewis (12) for the estimation of BSP "Lm" and "BSP fluid compartment."
METHODS

A. Procedure in dogs
Fifteen studies were conducted on 6 trained adult mongrel dogs, weighing between 16 and 30 kg, which had previously undergone splenectomy, cholecystectomy, and installation of a Thomas duodenal fistula apparatus (17) . At the time of an experiment the fistula was opened to permit visualization of the Ampulla of Vater through which a no. 5 or no. 6 Fr. olive-tipped ureteral catheter was inserted and advanced about 5 or 6 cm into the common bile duct. The dog was then placed upright in a sling. Bile was collected by gravity or, when it was particularly viscous, by gentle aspiration with a tuberculin syringe. Venous blood samples were collected in heparinized tubes. After obtaining blood and bile samples for analytical blanks, BSP in 5 per cent dextrose was infused intravenously for 1 hour at a constant rate of 0.4 to 0.5 mg per minute per kg (roughly twice the anticipated BSP "Tm") using a Bowman pump. During the last 30 minutes of this infusion 4 blood samples were collected at 10 minute intervals. During the second and third hours this procedure was repeated at BSP infusion rates of approximately 0.2 to 0.3 and 0.5 to 0.6 times the initial rate, respectively. In 6 studies a rapid BSP infusion (1 to 1.5 times the initial rate) was administered during the fourth hour in order to achieve a very high plasma level. Bile was obtained continuously and collected in successive separate graduated tubes at intervals of 10 to 15 minutes. Plasma volume was measured during the course of each study using I"31-labeled human serum albumin. The activity of a plasma sample obtained 10 minutes after tracer injection was compared with that of an aliquot of the injectate diluted to known volume with isotope-free "carrier" plasma to avoid adsorption of tracer to glass. At the end of each study the rates of delivery of the Bowman pump were calibrated.
B. Procedure in man Studies were conducted on 4 normal male volunteers, on 15 hospital patients without liver disease, and on 15 patients with various hepatic disorders. A second study was conducted on 2 of the normal volunteers 3.5 months after the first determination. The procedure was begun about an hour after a fat-free breakfast. After obtaining an initial blood sample BSP was infused for 1 hour at a constant rate of approximately 0.3 mg per minute per kg. Four venous blood samples were drawn at 10 minute intervals during the last 30 minutes of this infusion. This procedure was repeated at infusion rates usually 0.3 and 0.6 times the initial rate during the second and third hours, respectively. In the presence of liver disease the same procedure was followed, but all infusion rates were scaled down to 25 to 50 per cent of those employed in normal subjects. A rapid estimation of the BSP concentration in the first two blood specimens was carried out so that, if necessary, the subsequent infusion rates could be adjusted to avoid BSP concentrations outside the range of 2.5 to 15 mg per 100 ml. Plasma volume was measured during the first hour in all subjects using I"3-labeled human serum albumin.
C. Analytical methods Plasma. One ml of each plasma sample was diluted by the addition of 10 ml of normal saline and 0.2 ml of 132 TRANSPORT AND STORAGE OF BSP 20 per cent potassium hydroxide. The optical density was determined in a Beckman DU spectrophotometer at 580 mit. The optical density of a similarly treated plasma "blank" (obtained before the infusion of BSP) was subtracted. Standard curves for this determination were prepared by the addition of known amounts of BSP to canine plasma and to both normal and icteric human plasma. It was found that accurate results could be obtained in icteric plasma provided that 15 minutes were allowed for complete color change of bilirubin after alkalinization and provided the appropriate blank was subtracted.
Bile. The determination of BSP concentration in bile was complicated by the finding that the spectrophotometric recovery of BSP added to bile was often significantly reduced when the bile was diluted in the range of 200-to 1,000-fold. The reason for this phenomenon was not apparent, but it was found empirically that accurate measurement of BSP could always be obtained if the final dilution of bile was less than 200-fold. Since the BSP concentrations encountered in dog bile necessitated a higher dilution, this problem was circumvented by the addition of "blank" bile to the dilute bile specimens. A pooled control bile sample, obtained before BSP infusion, served as the source of the "blank" bile.
All bile samples were first diluted 100 times with distilled water. One ml of the diluted sample was then mixed with 1 ml of a fivefold dilution of the "blank" bile, 20 ml of water, and 0.4 ml of 20 per cent potassium hydroxide and the optical density determined at 580 m,. The optical density of a similarly treated control bile was subtracted.
Infusion mixture. Concentration of BSP in the infusion mixture was determined at 580 my after appropriate aqueous dilution and addition of alkali.
D. Calculation of Tm and S
The values of plasma BSP concentration were plotted on a linear scale against time. The rate of change of BSP concentration (Ap/At) during the last 30 minutes of each infusion period was calculated by application of the method of least squares (16) to the 4 points obtained during that time, although in most instances a reasonably straight line through the 4 points could have been fitted by eye. A value of hepatic removal rate was determined for each infusion period, and Tm and S were calculated as described under "Theoretical Considerations." Figure 1 . Even when excessively high plasma levels (22.4 to 48.3 mg per 100 ml) were produced at the end of six studies by rapid BSP infusion there was no further increase in excretory rate, so that it was apparent that the maximal capacity for BSP transport had been achieved. The BSP excretory rate, averaged 0.98 and 0.36 to 0.80 ml per minute in the two dogs). Corresponding to this increase there was a reciprocal reduction in biliary BSP concentration which, however, was not observed until an additional 2 to 3 ml of the bile had been collected. This volume is somewhat smaller than a previous estimate of about 5 ml for the "dead space" of the canine biliary tract (18) , possibly because the common duct and major hepatic ducts were maintained in a collapsed state by continuous aspiration in the present studies. Because of the "dead space" lag between flow and concentration changes, the calculated BSP excretory rate showed an abrupt increase followed by a decrease below the control rate. However, the average BSP excretory rate over the entire period of dehydrocholate effect did not differ significantly from the control excretory rate despite the inhibition of removal of Enterohepatic circulation of BSP. When estimations of Tm and S are undertaken without bile collection (as in the studies in man which follow), an error might arise if a significant quantity of the excreted BSP were reabsorbed. An investigation of the magnitude of intestinal absorption of this dye was therefore carried out. In two dogs, 600 mg of BSP was administered into the duodenum (48 ml of 1,250 mg per 100 ml solution in normal saline given over a 40 minute period). Within 30 minutes after introduction of the dye measurable quantities appeared in the bile. Maximal bile concentration was achieved in 1 hour in one dog (648 mg per 100 ml) and in 2 hours in the other (535 mg per 100 ml) and decreased thereafter, reaching levels under 50 mg per 100 ml within 4 hours. There was no increase in bile flow. Of the total administered dose the fraction recovered in bile in the two dogs at the end of 2 hours was 2.6 and 2.3 per cent, and at the end of 3.5 hours 4.0 and 4.7 per cent, respectively.
In another study 340 mg of BSP was dissolved in 15 ml of dog bile and administered into the duodenum. Only 1.4 per cent was recovered in the bile excreted over the next 4 hours. These observations are similar to those of Lorber and associates (19) in the anesthetized dog, and indicate a very limited interestinal absorption of BSP. Reabsorption of the BSP conjugates normally excreted in the bile may be even more limited. When bile (containing 350 mg of BSP) was collected from a dog receiving an intravenous BSP infusion and administered into the duodenum of another dog, no BSP was detectable in the bile excreted by the latter animal over the next 3 hours.
B. Normal man
As in the dog, linear rates of change of plasma BSP concentration were observed during the latter half of each infusion period (Figure 3) . The values of Tm and S were calculated as described under "Theoretical Considerations" and as illustrated in Figure 3 . The relationship between R and Ap/z&t proved to be approximately linear in most instances. In order to illustrate 1137 this relationship on a single composite graph (Figure 4) , the three values of R in each subject were subjected to the operation R'= R-(100/S) + [10 -Tm (100/S) l, so that the three points (Avp/At, R') fell about the least squares line R' = 10 + 100 (Ap/At). This operation does not disturb the relative positions of the three points, and it can be seen from Figure 4 that the actual relationship between R and Ap/zAt adhered rather closely to the postulated straight line in most subjects. Deviations from linearity appeared to be entirely random and can probably be attributed to methodological errors or failure to maintain a steady state for 3 hours.
In four normal males the average Tm was 10.3 mg per minute and S was 85 mg per mg per 100 ml. In eight hospital "normal" males (without liver disease) the average Tm was 9.1 mg per minute and S was 58 mg per mg per 100 ml. The mean for both groups was Tm = 9.5 ± SD 1.9 mg per minute and S = 67 + SD 28 mg per mg per 100 ml. In hospital "normal" females Tm was 7.1 + SD 0.8 mg per minute and S = 57 + SD 19 mg per mg per 100 ml. The individual results are shown in Table II and in Figure 5 . In men but not in women there was a positive correlation between Tm and body weight (R = 0.66, p < 0.05) and between Tm and surface area (R = 0.82, p < 0.01). No correlation was apparent between S and weight or between S and surface area in either sex. In view of the limited number of subjects, no definite conclusion can be drawn regarding the relationship between various indices of body size and the values of Tm and S, and therefore no empirical correction for weight or surface area was applied in man. C. Liver disease Patients were selected who had either primarily hepatocellular disease (hepatitis, acute fatty infiltration) or primarily obstructive disease (extrahepatic obstruction, chlorpromazine jaundice) on the theory that there might be a greater depression of S in the former and a greater depression of Tm in the latter group. However, as shown in Table III and in Figure 5 both Tm and S were reduced to approximately the same extent in patients with hepatocellular and obstructive disease. The only exception was F.S., a patient with chlorpromazine jaundice entering a period of rapid recovery at the time of the study, whose storage capacity fell within the normal range. It should be noted that all the patients with obstructive jaundice had developed symptoms at least one week before the study.
Three patients with Dubin-Johnson syndrome (chronic idiopathic jaundice) were studied, all of whom had the characteristic features of this disorder (20) . In each instance the diagnosis had been established by hepatic biopsy which revealed typical centrolobular pigmentation. Patient D.D. was the nephew of M.R.' As shown in Table III tients was virtually zero whereas the storage capacity was well within the range established for normal subjects. In Patient J.L. the plasma BSP concentration was followed for 24 hours after termination of the actual study. During the first 8 hours it diminished from 19.1 to 13.6 mg per 100 ml. At the end of 16 hours the plasma level was still elevated (9.4 mg per 100 ml) indicating an extremely slow excretion of dye.
D. Toxicity
In six studies of the dog, the rapid infusion of BSP during the fourth hour increased the total administered dose to approximately 1,500 to 1,800 mg compared to the 800 to 1,000 mg given in the course of the usual 3 hour procedure. In three of these, toward the end of the fourth hour, there was a sharp diminution in bile flow and BSP excretion rate. All three appeared well when the study was terminated but began vomiting about 4 hours later. In one, whose bile was still being drained by way of the common duct catheter, the vomiting subsided within an hour and the dog was entirely well thereafter. The other two, in whom the catheter had been removed and the fistula closed, died within 6 hours of the onset of symptoms. Postmortem examination revealed severe gastrointestinal hemorrhage, most marked in the proximal small intestine. The maximal excretory rate was achieved when the plasma BSP concentration exceeded approximately 3 mg per 100 ml, and further elevation of plasma concentration to as high as 48 mg per 100 ml did not result in any further increase in the rate of BSP excretion. Assuming a comparatively constant hepatic blood flow, this represents at least a 16-fold range in the quantity of BSP presented to the liver per unit time. In view of the variation in biliary BSP concentration encountered in these dogs, the limiting factor in BSP transport does not appear to be a fixed biliary concentration maximum as suggested by the studies of Brauer and Pessotti for anesthetized animals (3) .
Although it has been shown that a major proportion of BSP appears in the bile in the form of chromotographically distinct conjugates (21) (22) (23) (24) , it is apparent that conjugation is not essential for BSP secretion since a considerable amount of unconjugated BSP is also found in all species. However, in view of the constant ratio between the amount of BSP and its conjugates., which was observed during concturrent studies (22) , one cannot be certain whether the BSP Tm refers to a single transport mechanism or to the sum of separate transport mechanisms for BSP and each of its conjugates.
The magnitude of the average estimated Tm in dogs (1.9 mg per minute per 10 kg) is consistent with previous observations in this laboratory (9, 10) , but is considerably lower than the Lm of 4.4 mg per minute per 10 kg estimated by Mason, Hawley and Smith (11) . A possible explanation for this difference is that Mason and co-workers employed a correction for variation in plasma concentration which did not take the storage phenomenon into account. If the L,.l was calculated during a period of increasing concentration (as it was in the one illustration presented by these authors), this could have led to a considerable overestimation of secretory function.
The degree of variation in the Tm from time to time in a given animal (Table I) suggests a comparable degree of variability in the biological factors which determine transport maximum.
While methodological factors may have contributed to this variation, it is obvious that one must exercise caution in equating the secretory transport maximum simply to liver mass. The finding that measured output in the bile was equal, on the average, to 87.5 per cent of the estimated Tm indicates that biliary secretion must be the major mechanism for continuous elimination of BSP despite the fact that some extrahepatic removal is known to occur (10, 25 hepatic circulation and which are involved in normal bile production (26) . Any change in the actual BSP secretory rate must of course affect the calculation of Tm and S, which is based on the assumption of a 3 hour steady state with respect to BSP transport and storage. If the entire procedure could be shortened, the effect of this phenomenon, when it does occur, would be minimized. However, in the course of exploratory studies it became apparent that one cannot be sure of the establishment of a constant hepatic BSP removal rate within less than 30 minutes of the institution of a given rate of infusion. Thereafter, an additional 30 minutes is required for the reliable estimation of Ap/At and R. Thus it appeared unwise to allow less than 1 hour for each infusion period. The magnitude of the error caused by a diminishing BSP Tm can be estimated by substituting three appropriate hypothetical sets of values for R, Tm and S into Equation 1 and obtaining the corresponding values for Ap/At. When the three sets of values for R and Ap/At thus obtained were treated in the same manner as experimental data in estimating Tm and S, it was found that a 15 per cent diminution in BSP Tm over the course of 3 hours would lead to a 10 per cent underestimation of the initial transport maximum. The value of S would be overestimated by 6 per cent. These errors are not excessive, but data gathered over periods longer than 3 hours might well prove unreliable.
In man, the existence of a rate-limited BSP transport mechanism is indicated by the achievement of a state in which hepatic removal rate is independent of absolute plasma concentration and related only to the rate of change of plasma concentration. The mean Tm in normal subjects (8.6 + SD 1.9 mg per minute) is considerably lower than the maximal secretory rate of 18.3 mg per minute estimated previously by Verschure (15) . The latter figure was calculated by application of the formula of Mason, Hawley and Smith (11) to data obtained during a single BSP infusion at approximately 25 mg per minute. The actual data published by Verschure are, in fact, quite comparable to those observed during the rapid initial infusion employed in the method presented here. However, as shown in Figure 3 , the hepatic BSP removal rate is regularly very high under these circumstances due to the rapid accumulation of BSP in storage, so that this removal rate cannot be equated simply to the rate of secretion. In earlier work with BSP, Bradley, Ingelfinger, Bradley and Curry (14) found that an infusion rate of approximately 3 mg per minute per m2 (or 5.2 mg per minute per 1.73 m2) was the maximal rate at which continuously rising plasma BSP concentrations could be avoided in all their normal subjects. They suggested that this might represent an approximation to the minimal normal value of BSP Tm, and this estimate proves in fact to be roughly comparable to the lowest values of BSP Tm encountered in the present series (Table II) .
Concentration of BSP in hepatic parenchyma. The accumulation of BSP within the hepatic parenchyma appears to proceed toward an equilibrium state in which the quantity (and hence the concentration) of "stored" material is directly proportional to the concentration of dye in the surrounding plasma. The liver behaves, in this respect, as though it were an extension of the plasma volume, and the relative storage capacity, S, actually has the dimensions of a "volume." However, the magnitude of S, when compared with the actual size of the liver, indicates that BSP concentration in the liver cells must be many times that in the plasma.
Assuming a liver mass of approximately 250 g per 10 kg in the dog and 1,500 g in man, the average values for S of 25 mg per mg per 100 ml per 10 kg and 63 mg per mg per 100 ml in the two species would suggest that, with respect to plasma, the liver tends to concentrate BSP at least tenfold in the dog and fourfold in man. The range of normal values for S suggests that there is considerable variation in the biological mechanisms by which this concentration ratio is maintained from one subject to another and also, at least in the dog, from time to time in a given animal. This variation is greater than that observed in the Tm.
A high concentration ratio between liver and plasma might imply that some constituent of the liver cell has an affinity for BSP relatively greater than that of plasma protein. This would account for an ultimate relationship between liver and plasma concentrations but would certainly not explain the rapidity with which BSP, and other strongly protein-bound dyes such as rose bengal 1 141 (27) and indocyanine green (28) , actually move across the liver cell membrane. More detailed understanding of the storage phenomenon must also take into account the possible role of BSP conjugation, since alteration of chemical structure might favor the accumulation of larger amounts of dye in the liver. However, as in the case of biliary secretion, there is no evidence at present to indicate whether or not conjugation plays an essential role in the storage process.
Relationship between storage and transport.
In view of the anatomical relationship between the sinusoids, the liver cells, and the bile canaliculi, it might be postulated that plasma BSP is first taken up and stored in high concentration in liver cells from which it is then transported into the biliary tract (where it reaches even higher concentrations). However, it is also possible that there is a direct route of transport between plasma and bile and that the stored BSP is a more or less separate pool in equilibrium with the plasma. The latter possibility seems less likely when the observations with sodium dehydrocholate are considered. It was shown by Cantarow and Wirts (29) that the biliary excretion of BSP is markedly retarded when sodium dehydrocholate and BSP are administered simultaneously. In the present studies, by contrast, dehydrocholate was administered only after a large amount of BSP was already stored in the liver, and there was no reduction in BSP excretion. Thus, when hepatic removal of BSP from the plasma is partially blocked by dehydrocholate it becomes apparent that the dye can be secreted directly from hepatic parenchymal storage. Although the biliary secretion of BSP may depend upon the prior storage of dye within the liver cells, it is also obvious from the studies on patients with Dubin-Johnson syndrome that secretory transport can be markedly depressed even in the presence of an entirely normal storage capacity.
BSP Tm and S in liver disease. While a depression of BSP Tm was anticipated in all types of hepatic disease, a more nearly normal storage capacity might have been expected in the patients with biliary obstruction. It is not clear whether the reduced storage capacity in these patients is an indication of secondary parenchymal damage or whether it is due to the retention of specific substances which interfere with BSP storage.
However, it is obvious that measurements of Tm and S could not be used clinically to distinguish between obstructive and hepatocellular jaundice.
Extrahepatic removal of BSP, which can be practically disregarded when hepatic function is normal (10, 30) , should not be increased in patients with hepatic disease provided the BSP infusion rates are reduced sufficiently to avoid excessively high plasma concentrations. Nevertheless, the ratio of extrahepatic to total BSP removal is necessarily greater when hepatic function is impaired and this will affect the estimation of Tm or S or both (depending upon the behavior of the extrahepatic mechanisms). Hence the reduction in Tm and S in patients with liver disease must have been, if anything, even more marked than the values in Table III 
